Publication:
Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease

dc.contributor.authorERGELEN, RABİA
dc.contributor.authorYILMAZ, YUSUF
dc.contributor.authorsYilmaz, Yusuf; Senates, Ebubekir; Yesil, Atakan; Ergelen, Rabia; Colak, Yasar
dc.date.accessioned2022-03-13T12:46:22Z
dc.date.accessioned2026-01-11T19:11:38Z
dc.date.available2022-03-13T12:46:22Z
dc.date.issued2014
dc.description.abstractAims: Growing evidence suggests that not only type 2 diabetes (T2D) but also prediabetes (PD) is common in patients with non-alcoholic fatty liver disease (NAFLD). However, few data exist on how PD impacts the histological characteristics of NAFLD patients. In this exploratory study, we sought to investigate the associations of PD and T2D with the severity of the histological features in patients with NAFLD. Methods: The population consisted of 280 patients with biopsy-proven NAFLD. The associations of PD and T2D with the severity of histological features of NAFLD were analyzed using multiple logistic (or ordinal logistic) regression models after adjustment for confounding factors. Results: PD and T2D was noted in 102 (36.4%) and 92 (32.8%) of patients, respectively. Of the 92 patients with T2D, ten (10.9%) were diagnosed de novo after the OGTT. PD and T2D were significantly associated with more severe portal inflammation (P < 0.01); the adjusted odds ratios (ORs) of PD and T2D for having a higher grade of portal inflammation were 1.8 [95% CI, 1.1, 3.2] and 2.6 [95% CI, 1.3, 5.8]), respectively. A similar relationship was observed for liver fibrosis (P < 0.001); specifically, the adjusted ORs of PD and T2D for having a higher grade of hepatic fibrosis were 2.4[95% CI, 1.3, 3.7] and 3.8 [95% CI, 1.9, 6.1]), respectively. Conclusion: Not only T2D but also PD is independently associated with portal inflammation and fibrosis in NAFLD patients. PD may be useful as a clinical indicator of patients who are likely to have already more severe histological findings. (C) 2014 Elsevier Inc. All rights reserved.
dc.identifier.doi10.1016/j.jdiacomp.2014.01.013
dc.identifier.eissn1873-460X
dc.identifier.issn1056-8727
dc.identifier.pubmed24602757
dc.identifier.urihttps://hdl.handle.net/11424/237921
dc.identifier.wosWOS:000335717800015
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF DIABETES AND ITS COMPLICATIONS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPrediabetes
dc.subjectNon-alcoholic fatty liver disease
dc.subjectFibrosis
dc.subjectClinical study
dc.subjectMETABOLIC SYNDROME
dc.subjectGLUCOSE-TOLERANCE
dc.subjectSTEATOHEPATITIS
dc.subjectNAFLD
dc.subjectPROGRESSION
dc.subjectPREVALENCE
dc.subjectBIOMARKERS
dc.subjectDIAGNOSIS
dc.subjectMARKER
dc.titleNot only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage331
oaire.citation.issue3
oaire.citation.startPage328
oaire.citation.titleJOURNAL OF DIABETES AND ITS COMPLICATIONS
oaire.citation.volume28

Files